Sign In
Buy KNBIF
$0.0202
+0 (+0%)
At Close: Jul 31, 2026
Kane Biotech to Release Fourth Quarter and Full Year 2023 Financial Results on March 26, 2024 – Conference Call to Follow
04:10pm, Tuesday, 19'th Mar 2024
WINNIPEG, Manitoba, March 19, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, developme
Kane Biotech Receives Bioscience Association Manitoba Company of the Year Award
09:00am, Friday, 08'th Mar 2024
WINNIPEG, Manitoba, March 08, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company” or “Kane Biotech” or “Kane”) announces that at the Bioscience Association of
Dr. Robert Huizinga Elected to the Kane Biotech Board and Appointed Executive Chair
08:00am, Thursday, 22'nd Feb 2024
WINNIPEG, Manitoba, Feb. 22, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company” or “Kane Biotech” or “Kane”) announces that at the special meeting of the sha
Kane Biotech Files New Patent on revyve™ Antimicrobial Wound Gel Spray
08:30am, Wednesday, 31'st Jan 2024
Kane will introduce its unique spray gel at the Boswick Burn and Wound Care Symposium Kane will introduce its unique spray gel at the Boswick Burn and Wound Care Symposium
Kane Biotech to Present its revyve™ Antimicrobial Wound Gel at Boswick Burn and Wound Care Symposium
12:03pm, Thursday, 25'th Jan 2024
WINNIPEG, Manitoba, Jan. 25, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company” or “Kane Biotech” or “Kane”) today announces that the Company will be present
Kane Biotech Announces Special Meeting of Shareholders
04:30pm, Thursday, 18'th Jan 2024
WINNIPEG, Manitoba, Jan. 18, 2024 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company”, “Kane” or “Kane Biotech”) announces today that on February 20, 2024, the Com
Kane Biotech Announces Correction to Press Release
02:33pm, Friday, 29'th Dec 2023
WINNIPEG, Manitoba, Dec. 29, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company”, “Kane” or “Kane Biotech”) today announces a correction to its press release
Kane Biotech Announces Amendment to its Credit Facility
04:05pm, Thursday, 28'th Dec 2023
WINNIPEG, Manitoba, Dec. 28, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company”, “Kane” or “Kane Biotech”) announces today that on December 20, 2023, the Com
Kane Biotech Receives Offer for its Interest in STEM Animal Health
08:29am, Wednesday, 20'th Dec 2023
WINNIPEG, Manitoba, Dec. 20, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V:KNE OTCQB:KNBIF) (the “Company”, “Kane” or “Kane Biotech”) announces today that on December 19, 2023, it sign
Kane Biotech Announces Improved Third Quarter 2023 Financial Results
04:05pm, Tuesday, 28'th Nov 2023
29% Increase in Product and Services Revenue; 26% Increase in Total Revenue 29% Increase in Product and Services Revenue; 26% Increase in Total Revenue
Kane Biotech to Release Third Quarter 2023 Financial Results on November 28, 2023 – Conference Call to Follow
07:45am, Tuesday, 21'st Nov 2023
WINNIPEG, Manitoba, Nov. 21, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, developmen
Kane Biotech Strengthens Board with Biotech Executive
01:45pm, Thursday, 16'th Nov 2023
Accomplished executive with over two decades of senior biotechnology expertise joins Kane's Board of Directors Accomplished executive with over two decades of senior biotechnology expertise joins Kane
Kane Biotech and ProgenaCare Global Launch Newly Rebranded revyve™ Antimicrobial Wound Gel at Advanced Wound Care Fall Forum
11:48am, Thursday, 02'nd Nov 2023
Name change reinforces a fresh start for chronic wounds with a triple threat approach Name change reinforces a fresh start for chronic wounds with a triple threat approach
Kane Biotech to Release Second Quarter 2023 Financial Results on Aug 29, 2023 – Conference Call to Follow
07:30am, Tuesday, 22'nd Aug 2023
WINNIPEG, Manitoba, Aug. 22, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, developmen
Kane Biotech to Release First Quarter 2023 Financial Results on May 25, 2023 – Conference Call to Follow
04:05pm, Thursday, 18'th May 2023
WINNIPEG, Manitoba, May 18, 2023 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (the “Company” or “Kane Biotech”), a biotechnology company engaged in the research, development
